LEASES

12 Months Ended

Sep. 30, 2024

Leases [Abstract]

LEASES

12. LEASES

The Company leases office and research and development facility leases under non-cancelable operating leases for various terms through 2031. Certain lease agreements include rent abatement periods, and rental increases throughout the term. Operating lease costs are included within cost of revenue, selling and marketing, research and development, and general and administrative expenses, dependent upon the nature and use of the ROU asset, in the Company’s consolidated statements of operations and comprehensive income (loss).

The following table provides the components of lease cost recognized in the consolidated statements of operations and comprehensive income (loss) for the periods presented (amounts in thousands):

	Twelve Months Ended September 30,
	2024		2023		2022
Operating lease cost	$	1,784	$	2,025	$	1,881
Variable lease cost	633		319		385
Total lease cost(1)	$	2,417	$	2,344	$	2,266

1)Short-term lease costs incurred by the Company for the twelve months ended September 30, 2024, 2023 and 2022 were immaterial.

Supplemental cash flow information related to leases was as follows (amounts in thousands):

	Twelve Months Ended September 30,
	2024		2023		2023
Right of use assets acquired under new operating leases	$	1,947	$	—	$	—
Cash paid for amounts included in the measurement of lease liabilities	1,960		2,368		2,135

Other information related to leases as of the balance sheet dates presented are as follows:

	Twelve Months Ended September 30,
	2024		2023
Weighted-average remaining lease term (years) - operating leases	5.3		4.3
Weighted-average discount rate - operating leases	3.6	%	3.7	%

Maturities of operating lease liabilities as of September 30, 2024 were as follows (amounts in thousands):

	Operating Leases
2025	$	1,008
2026	1,191
2027	1,141
2028	840
2029	664
Thereafter	843
Total lease payments	5,687
Less: amount representing interest	(652)
Present value of future lease payments	$	5,035